Skip to main content
. Author manuscript; available in PMC: 2017 Apr 2.
Published in final edited form as: Clin Ther. 2016 Apr 2;38(4):821–830. doi: 10.1016/j.clinthera.2016.03.011

Figure 1.

Figure 1

Example graphical display showing the distribution of maximum post-baseline grades reported by patients during treatment in a phase 2 cancer clinical trial (Clin Trials. 2015 Nov 4. pii: 1740774515615540. PMID:26542025). Grades are based on items modified for patient use from the Common Terminology Criteria for Adverse Events (CTCAE).